Identification and characterization of autoreactive T cell responses to bullous pemphigoid antigen 2 in patients and healthy controls.
Lioba Büdinger(Universitätsklinikum Aachen), Michael Hertl(Philipps University of Marburg), Luca Borradori(University Dermatology), Kim B. Yancey(National Institutes of Health), S. Ferenčík(Ruhrlandklinik), Hans F. Merk(RWTH Aachen University), H. Grosse‐Wilde(Ruhrlandklinik), Christina Yee(Boston Children's Hospital), Rüdiger Eming(Philipps University of Marburg)
Cited by 235
Related Papers
Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus
|Journal of the American Academy of Dermatology|2008|586
Diagnosis and management of pemphigus: Recommendations of an international panel of experts
|Journal of the American Academy of Dermatology|2018|373
Definitions and outcome measures for bullous pemphigoid: Recommendations by an international panel of experts
|Journal of the American Academy of Dermatology|2011|370
Guideline on allergen-specific immunotherapy in IgE-mediated allergic diseases
|Allergo Journal International|2014|348
Updated S2K guidelines on the management of pemphigus vulgaris and foliaceus initiated by the european academy of dermatology and venereology (EADV)
|Journal of the European Academy of Dermatology and Venereology|2020|332